🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary trial objective in this single arm trial is to assess the safety an...
Status
Completed
Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Start Date
2009-04
Trial ID
NCT00879866
Treatments Being Tested
This observational study will evaluate the efficacy and safety of bevacizum...
Status
Completed
Location
Clinique Esquirol Saint Hilaire
Start Date
2010-09-30
Trial ID
NCT01343901
Treatments Being Tested
Lung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Status
Recruiting
Location
Research Site
Start Date
2023-07-28
Trial ID
NCT06068049
This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11
Trial ID
NCT06665087
This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2017-05-12
Trial ID
NCT03134638
This study is a prospective, open-label, randomized, multicenter, two-cohor...
Status
Recruiting
Location
The Second Affiliated Hospital of Dalian Medical University
Start Date
2025-06-25
Trial ID
NCT07285382
Treatments Being Tested
The goal of this project is to characterize the genetic profile of patients...
Status
Recruiting
Location
Centre Hospitalier Annecy Genevois
Start Date
2015-07
Trial ID
NCT02511288
BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Status
Active Not Recruiting
Location
University of Alabama
Start Date
2022-03-31
Trial ID
NCT05256290
Treatments Being Tested
The objective of this study is to assess the overall response rate, evaluat...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-01-09
Trial ID
NCT05661955
Treatments Being Tested
This Phase Ib/IIa study is evaluating the safety, tolerability, pharmacokin...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2026-01-29
Trial ID
NCT07208149
Treatments Being Tested